Form 10-Q · Quarterly report
Mondelez International 10-Q, filed Oct 29, 2026
- Filed
- CIK
- 0001103982
- Accession no.
- 0001628280-26-068256
Summary
Mondelez International said cocoa prices are expected to remain elevated, it paid about $20 million in IEEPA tariffs and received about $14 million in refunds as of Sept. 30, 2026, and it completed the first phase of a $1.2 billion ERP system implementation covering North America and Latin America. The company also said Russia and Ukraine generated 3.1% and 0.3% of third-quarter 2026 consolidated net revenue, respectively, and that Middle East conflict impacts have not been material to date.
Key points
- The U.S. Supreme Court ruled during the first quarter of 2026 that tariffs imposed under IEEPA were unlawful.
- Mondelez completed the first phase of its ERP System Implementation for North America and Latin America in Q3 2026; remaining phases are expected by year-end 2028.
- Russia and Ukraine generated 3.1% and 0.3% of Mondelez's Q3 2026 consolidated net revenue, respectively.
- Middle Eastern countries impacted by conflict generated about 1.0% of Q3 2026 consolidated net revenue; Mondelez said the developments have not had a material impact to date.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. Overview of Business and Strategy Our core business is making and selling chocolate, biscuits and baked snacks, with additional businesses in adjacent, locally relevant categories including gum & candy, meals and beverages around the world. We aim to be the global leader in snacking. Our strategy is to drive long-term growth by focusing on four strategic priorities: accelerating consumer-centric growth, driving operational excellence, creating a winning growth culture and scaling sustainable snacking. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.